Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB
English, IR, News, RegulatoryToday, 2[nd] April 2024, an Extraordinary General Meeting was held in Diagonal Bio AB, reg. no. 559248–8984. Below is a summary of the resolutions passed. All resolutions were passed with the required majority.The board's proposal on reducing…
Diagonal Bio appoints Karin Wehlin as new CEO
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ.) (“Diagonal Bio” or “the Company”) is pleased to announce that the Board of Directors has appointed Karin Wehlin as Chief Executive Officer (CEO) of Diagonal Bio. Karin Wehlin is currently Diagonal…
Notice to attend the extraordinary general meeting of Diagonal Bio AB
English, IR, News, RegulatoryShareholders in Diagonal Bio AB, 559248-8984, are hereby invited to attend an extraordinary general meeting on Tuesday, 2nd of April, 2024, at 13:00 CET at The Spark, conference room 10, Medicon Village, Scheeletorget 1 Lund.Right to Participate…
The Board of Directors decides on a preferential rights issue of units in order to finance future development
English, IR, MAR, News, RegulatoryNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION…
Diagonal Bio AB Year-end Report 2023
English, Interim, IR, News, Regulatory, Report, Yearend“Looking back at 2023, I am proud to point out the significant steps we have made in our development, including the key achievements such as the CE-marking of LAMPlify® according to Low Voltage Directive (LVD) 2006/95/ EC. A highlight…
Diagonal Bio AB has signed a distribution agreement with Techtum Lab AB
IR, MAR, News, Regulatory, SwedishDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") has signed a distribution agreement with Techtum Lab AB ("Techtum Lab"). Techtum Lab is granted the rights to distribute Diagonal Bio's analytical instrument, LAMPlify®, in Sweden…
Diagonal Bio AB (publ) genomför en effektivisering av marknadskommunikation och ändrar från svenska till engelska för pressreleaser och delårsrapporter.
IR, News, SwedishDiagonal Bio (“Bolaget”) meddelar att Bolaget valt att effektivisera sin marknadskommunikation och framöver endast kommer att tillhandahålla pressmeddelanden och delårsrapporter på engelska. Diagonal Bios årsredovisningar…
Diagonal Bio AB (publ) lämnar uppdatering kring den finansiella situationen
IR, MAR, News, Regulatory, SwedishI augusti 2023 kommunicerades att Diagonal Bio erhöll en finansiering där lån och nytt ägarkapital skulle ta bolaget till Q1 2024. De lån som Diagonal Bio erhöll hösten 2023 om totalt 2,6 MSEK ska återbetalas…
Kvalificerade personaloptioner och teckningsoptioner i Diagonal Bio AB (publ.) avslutas
IR, News, Regulatory, SwedishI enlighet med den överenskommelse som gjordes i samband med Jack Egelund Madsens avgång som VD den 23 november 2023, har styrelsen idag på styrelsemöte beslutat att avsluta de kvalificerade personaloptioner och teckningsoptioner…
Valberedning utsedd i Diagonal Bio AB (publ.) inför årsstämman 2024
IR, News, SwedishI enlighet med de principer för inrättande av valberedning som tidigare beslutats på årsstämman 2023, har följande valberedning utsetts för Diagonal Bio AB (publ.) inför årsstämman 2024.Valberedningen…
